المؤلفون: Morè S; Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy., Corvatta L; Department of Medicine, UOC Medicina Fabriano, Ancona, Italy., Maracci L; Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy., Costantini B; Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy., Olivieri A; Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy., Offidani M; Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy.

المصدر: Expert review of hematology [Expert Rev Hematol] 2020 Apr; Vol. 13 (4), pp. 351-362. Date of Electronic Publication: 2020 Mar 12.

نوع المنشور: Journal Article; Review; Video-Audio Media

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy* , Hematopoietic Stem Cell Transplantation* , Maintenance Chemotherapy*, Lenalidomide/*therapeutic use , Multiple Myeloma/*therapy, Disease-Free Survival ; Humans ; Multiple Myeloma/mortality ; Survival Rate ; Transplantation, Autologous

المؤلفون: Bouchacourt B; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Hospital MA; Department of Hematology, Institut Paoli-Calmettes, Marseille, France. hospitalma@ipc.unicancer.fr., Zemmour C; Department of Clinical Research & Innovation, Biostatics & Methodology Unit, Institut Paoli-Calmettes, Marseille, France., Rey J; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., d'Incan E; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Charbonnier A; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Mohty B; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Saillard C; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Bonnet S; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Collignon A; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Gelsi-Boyer V; Department of Pathology, Institut Paoli-Calmettes, Marseille, France., Mozziconacci MJ; Department of Pathology, Institut Paoli-Calmettes, Marseille, France., Blaise D; Department of Hematology, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France., Vey N; Department of Hematology, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.

المصدر: Annals of hematology [Ann Hematol] 2020 Apr; Vol. 99 (4), pp. 773-780. Date of Electronic Publication: 2020 Feb 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy*, Leukemia, Myeloid, Acute/*drug therapy, Aged ; Aged, 80 and over ; Allografts ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Blood Component Transfusion ; Combined Modality Therapy ; Cytarabine/administration & dosage ; Cytarabine/adverse effects ; Daunorubicin/administration & dosage ; Daunorubicin/adverse effects ; Disease-Free Survival ; Female ; Follow-Up Studies ; Hematopoietic Stem Cell Transplantation ; Humans ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/therapy ; Male ; Middle Aged ; Remission Induction ; Retrospective Studies ; Transplantation, Autologous ; Treatment Outcome

SCR Protocol: HDAC protocol

المؤلفون: Byun JM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Lee JO; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea jeongok77@gmail.com., Suh KJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Lee J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Shin DY; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Koh Y; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Hong J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Bang SM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Kim I; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

المصدر: Anticancer research [Anticancer Res] 2020 Jan; Vol. 40 (1), pp. 357-366.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy*, Anthracyclines/*therapeutic use , Leukemia, Myeloid, Acute/*drug therapy, Adolescent ; Adult ; Aged ; Anthracyclines/adverse effects ; Anthracyclines/pharmacology ; Cytarabine/therapeutic use ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Female ; Hematopoietic Stem Cell Transplantation ; Humans ; Idarubicin/pharmacology ; Idarubicin/therapeutic use ; Leukemia, Myeloid, Acute/pathology ; Male ; Middle Aged ; Multivariate Analysis ; Proportional Hazards Models ; Young Adult

المؤلفون: Fokas E; Emmanouil Fokas, MD, DPhil, and Claus Rödel, MD, University of Frankfurt, Frankfurt, Germany., Rödel C; Emmanouil Fokas, MD, DPhil, and Claus Rödel, MD, University of Frankfurt, Frankfurt, Germany.

مؤلفون مشاركون: German Rectal Cancer Study Group

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Dec 20; Vol. 37 (36), pp. 3562-3563. Date of Electronic Publication: 2019 Oct 09.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy* , Rectal Neoplasms*, Chemoradiotherapy ; Humans ; Neoadjuvant Therapy ; Rectum

المؤلفون: Al Saleh AS; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.; Division of Hematology and HSCT, Department of Oncology, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Sidiqi MH; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Sidana S; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Muchtar E; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Dispenzieri A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Dingli D; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Lacy MQ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Warsame RM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Gonsalves WI; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Kourelis TV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Hogan WJ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Hayman SR; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Wolf RC; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Kapoor P; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Buadi FK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Gertz MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

المصدر: American journal of hematology [Am J Hematol] 2019 Oct; Vol. 94 (10), pp. 1066-1071. Date of Electronic Publication: 2019 Jul 23.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy* , Peripheral Blood Stem Cell Transplantation*, Immunoglobulin Light-chain Amyloidosis/*therapy, Aged ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/therapeutic use ; Drug Therapy, Combination ; Female ; Humans ; Immunologic Factors/administration & dosage ; Immunologic Factors/therapeutic use ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/therapeutic use ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Progression-Free Survival ; Proteasome Inhibitors/administration & dosage ; Proteasome Inhibitors/therapeutic use ; Retrospective Studies ; Rituximab/administration & dosage ; Rituximab/therapeutic use ; Transplantation, Autologous ; Treatment Outcome

المؤلفون: Rodríguez-Veiga R; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Montesinos P; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain. montesinos_pau@gva.es.; CIBERONC, Instituto Carlos III, Madrid, Spain. montesinos_pau@gva.es., Boluda B; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Lorenzo I; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Martínez-Cuadrón D; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Salavert M; Department of Infectious Diseases, Hospital Universitari i Politècnic La Fe, València, Spain., Pemán J; Department of Microbiology, Hospital Universitari i Politècnic La Fe, València, Spain., Calvillo P; Department of Radiology, Hospital Universitari i Politècnic La Fe, València, Spain., Cano I; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Acuña E; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Villalba A; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Piñana JL; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Sanz J; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Solves P; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Senent L; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Vicente A; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Sempere A; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Cervera J; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Barragán E; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain., Jarque I; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Torres A; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain.; Asociación Medicina e Investigación (A.M.I.), Córdoba, Spain., Sanz MA; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain.; Department of Medicine, Universitat de València, València, Spain., Sanz GF; Department of Hematology, Hospital Universitari i Politècnic La Fe, Avda. Fernando Abril Martorell 106, CP: 46026, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain.; Department of Medicine, Universitat de València, València, Spain.

المصدر: Annals of hematology [Ann Hematol] 2019 Sep; Vol. 98 (9), pp. 2081-2088. Date of Electronic Publication: 2019 Jun 25.

نوع المنشور: Clinical Trial; Comparative Study; Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy* , Invasive Fungal Infections*/epidemiology , Invasive Fungal Infections*/prevention & control , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/epidemiology, Antifungal Agents/*administration & dosage, Adolescent ; Adult ; Aged ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors

المؤلفون: Sakaguchi T; Respiratory Center, Matsusaka Municipal Hospital, 1550, Tonomachi, Matsusaka, Mie, 515-0073, Japan; St. Marianna University School of Medicine, Division of Respiratory Medicine, 2-16-1 Sugao, Miyamae, Kanagawa, 216-8511, Japan. Electronic address: mchsakaguchi@city-hosp.matsusaka.mie.jp., Ito K; Respiratory Center, Matsusaka Municipal Hospital, 1550, Tonomachi, Matsusaka, Mie, 515-0073, Japan. Electronic address: kentarou_i_0214@yahoo.co.jp., Furuhashi K; Respiratory Center, Matsusaka Municipal Hospital, 1550, Tonomachi, Matsusaka, Mie, 515-0073, Japan. Electronic address: mchkazuki.f@city-hosp.matsusaka.mie.jp., Nakamura Y; Respiratory Center, Matsusaka Municipal Hospital, 1550, Tonomachi, Matsusaka, Mie, 515-0073, Japan. Electronic address: mch.y-nkmr@city-hosp.matsusaka.mie.jp., Suzuki Y; Respiratory Center, Matsusaka Municipal Hospital, 1550, Tonomachi, Matsusaka, Mie, 515-0073, Japan. Electronic address: mchyu-ta@city-hosp.matsusaka.mie.jp., Nishii Y; Respiratory Center, Matsusaka Municipal Hospital, 1550, Tonomachi, Matsusaka, Mie, 515-0073, Japan. Electronic address: mchnishii@city-hosp.matsusaka.mie.jp., Taguchi O; Respiratory Center, Matsusaka Municipal Hospital, 1550, Tonomachi, Matsusaka, Mie, 515-0073, Japan. Electronic address: mchosamutaguchi@city-hosp.matsusaka.mie.jp., Hataji O; Respiratory Center, Matsusaka Municipal Hospital, 1550, Tonomachi, Matsusaka, Mie, 515-0073, Japan. Electronic address: mch1031@city-hosp.matsusaka.mie.jp.

المصدر: Respiratory investigation [Respir Investig] 2019 Sep; Vol. 57 (5), pp. 466-471. Date of Electronic Publication: 2019 May 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101581124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-5353 (Electronic) Linking ISSN: 22125345 NLM ISO Abbreviation: Respir Investig Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy*, Antibodies, Monoclonal/*administration & dosage , Antineoplastic Agents, Immunological/*administration & dosage , Carcinoma, Non-Small-Cell Lung/*therapy , Lung Neoplasms/*therapy, Aged ; Aged, 80 and over ; Chemoradiotherapy/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Radiation Pneumonitis/epidemiology ; Radiation Pneumonitis/etiology ; Retrospective Studies

المؤلفون: Horvath N; Department of Haematology, Royal Adelaide Hospital , Adelaide , Australia., Spencer A; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia., Kenealy M; Cabrini Health, Australia and Monash University , Melbourne , Australia., Joshua D; Department of Haematology, Royal Prince Alfred Hospital , Camperdown , Australia, and Sydney University, Sydney, Australia., Campbell PJ; Department of Haematology, Andrew Love Cancer Centre , Geelong , Australia., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital , Hwasun , Republic of Korea., Hou J; Department of Hematology, Shanghai Changzheng Hospital , Shanghai , China., Qiu L; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College , Tianjin , China., Kalff A; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia., Khong T; Department of Clinical Haematology, Alfred Health-Monash University , Melbourne , Australia., Londhe A; Janssen Research & Development LLC , Titusville , NJ , USA., Siggins S; Janssen Cilag , Sydney , Australia., van Kooten Losio M; Janssen Cilag , Sydney , Australia., Eisbacher M; Janssen Cilag , Sydney , Australia., Prince HM; Cabrini Health, Australia and Monash University , Melbourne , Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne , Melbourne , Australia.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2019 Sep; Vol. 60 (9), pp. 2122-2133. Date of Electronic Publication: 2019 Feb 19.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*, Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Consolidation Chemotherapy/*methods , Induction Chemotherapy/*methods , Multiple Myeloma/*therapy, Administration, Oral ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bortezomib/administration & dosage ; Bortezomib/adverse effects ; Chemotherapy, Adjuvant/methods ; Consolidation Chemotherapy/adverse effects ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Dexamethasone/administration & dosage ; Dexamethasone/adverse effects ; Disease-Free Survival ; Female ; Humans ; Induction Chemotherapy/adverse effects ; Injections, Subcutaneous ; Male ; Middle Aged ; Multiple Myeloma/mortality ; Neoadjuvant Therapy/adverse effects ; Neoadjuvant Therapy/methods ; Prednisolone/administration & dosage ; Prednisolone/adverse effects ; Progression-Free Survival ; Thalidomide/administration & dosage ; Thalidomide/adverse effects ; Transplantation, Autologous

المؤلفون: Glynne-Jones R; Department of Radiotherapy, Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, UK. Electronic address: rob.glynnejones@nhs.net.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Aug 01; Vol. 30 (8), pp. 1188-1190.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Consolidation Chemotherapy* , Rectal Neoplasms*, Chemoradiotherapy ; Humans ; Poland

المؤلفون: Godfroy M; Chirurgical oncologie Department. ICO Cancer Center, René Gauducheau Centre, Saint Herblain, France marinegodfroy@orange.fr Cecile.Loaec@ico.unicancer.fr dominique.berton@ico.unicancer.fr Catherine.Guerin@ico.unicancer.fr Jean-Marc.Classe@ico.unicancer.fr., Loaec C; Chirurgical oncologie Department. ICO Cancer Center, René Gauducheau Centre, Saint Herblain, France marinegodfroy@orange.fr Cecile.Loaec@ico.unicancer.fr dominique.berton@ico.unicancer.fr Catherine.Guerin@ico.unicancer.fr Jean-Marc.Classe@ico.unicancer.fr., Berton D; Medical oncology Department, ICO Cancer Center, René Gauducheau Centre, Saint Herblain, France marinegodfroy@orange.fr Cecile.Loaec@ico.unicancer.fr dominique.berton@ico.unicancer.fr Catherine.Guerin@ico.unicancer.fr Jean-Marc.Classe@ico.unicancer.fr., Guérin-Charbonnel C; Clinical Research Department, ICO Cancer Center, Saint Herblain, France marinegodfroy@orange.fr Cecile.Loaec@ico.unicancer.fr dominique.berton@ico.unicancer.fr Catherine.Guerin@ico.unicancer.fr Jean-Marc.Classe@ico.unicancer.fr.; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Classe JM; Chirurgical oncologie Department. ICO Cancer Center, René Gauducheau Centre, Saint Herblain, France marinegodfroy@orange.fr Cecile.Loaec@ico.unicancer.fr dominique.berton@ico.unicancer.fr Catherine.Guerin@ico.unicancer.fr Jean-Marc.Classe@ico.unicancer.fr.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Jan 03; Vol. 33 (1), pp. 94-101. Date of Electronic Publication: 2023 Jan 03.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/surgery, Humans ; Female ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/surgery ; Retrospective Studies ; Consolidation Chemotherapy ; Propensity Score ; Neoadjuvant Therapy ; Cytoreduction Surgical Procedures ; Chemotherapy, Adjuvant ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use